Press Releases and Statements

The Consumer Healthcare Products Association (CHPA) today announced the appointment of Lisa Parks, RPh, to serve as its Senior Vice President of Regulatory & Scientific Affairs.

CHPA today released the below statement following a U.S. Food and Drug Administration (FDA) joint advisory committee meeting, which concluded that Opill®, a once-daily oral contraceptive, should be approved as the first oral contraceptive for use without a prescription:  

The Consumer Healthcare Products Association (CHPA) today released the below statement following the U.S. Food and Drug Administration’s (FDA) public release of briefing materials

Duffy MacKay, Consumer Healthcare Products Association (CHPA) Senior Vice President of Dietary Supplements, and co-author of the paper, Perspectives on the Use of Proprietary Blends in Dietary Supplements

CHPA’s SVP of Dietary Supplements, Duffy MacKay, responds to reporting on a recent research letter published in JAMA finding that 22 out of 25 melatonin products analyzed were mislabeled, containing variable amounts of the ingredient:

Most people who have flexible spending or health savings accounts think supplements should be covered as “medical expenses”

The Consumer Healthcare Products Association (CHPA) today announced senior staff changes to its Communications Department and Educational Foundation. Mike Tringale has been promoted to Senior Vice President, Communications and Public Affairs, and Mary Leonard has been promoted to Executive Director of CHPA’s Educational Foundation.

(WASHINGTON, DC) – The Consumer Healthcare Products Association (CHPA) Educational Foundation today announced the call for nominations for its 2023 U.S. Self-Care Marketing Awards. Winners will be announced at the eighth annual CHPA Educational Foundation Gala on November 15 at the Bellevue Hotel in Philadelphia.

(ORLANDO, Fla.) – The Consumer Healthcare Products Association (CHPA) released the following statement today congratulating its Senior Vice President of Regulatory & Scientific Affairs Barbara A. Kochanowski, Ph.D.,

CHPA applauds FDA for taking a critical step forward today in public health, which will remove many of the barriers and stigmas attached to this life-saving emergency therapy for opioid overdoses

(ORLANDO, Fla.) – The Consumer Healthcare Products Association (CHPA) today announced the appointment of Lisa Paley as Chair of its Board of Directors following its March board meeting held during the association’s annual Self-Care Leadership Summit (SLS) in Orlando, Florida.

CHPA released the below statement today following the U.S. Food and Drug Administration’s announcement that it will postpone its previously scheduled April 12 Nonprescription Drugs Advisory Committee meeting to reconsider the efficacy of oral phenylephrine.